argenx SE (ARGX)
371.16
+9.00
(+2.49%)
USD |
NASDAQ |
May 31, 16:00
370.91
-0.25
(-0.07%)
After-Hours: 20:00
argenx Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 62.29M |
| June 30, 2022 | 808.28M |
| June 30, 2021 | 1.103B |
| June 30, 2019 | 203.90M |
| June 30, 2018 | 1.938M |
| June 30, 2017 | 106.61M |
| Date | Value |
|---|---|
| June 30, 2016 | 49.59M |
| June 30, 2015 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| June 30, 2013 | 10.81M |
| March 31, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
62.29M
Minimum
Jun 2023
1.103B
Maximum
Jun 2021
544.45M
Average
506.09M
Median
Cash from Financing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Koninklijke Philips NV | -- |
| Trinity Biotech PLC | 18.85M |
| NuCana PLC | 1.758M |
| uniQure NV | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | -4.22% |